Insights and Clinical Implications from the pELVIS Registry for the Treatment of Aneurysms Involving the Iliac Bifurcation

© R A D C L I F F E C A R D I O L O G Y 2 0 1 9 Access at: www.VERjournal.com Preservation of internal iliac artery (IIA) flow has been previously evaluated in the literature. In that sense, placement of iliac branch devices (IBDs) represents one of the most popular endovascular options when anatomically feasible. The first paper reporting the results of The pErformance of iLiac branch deVIces for aneurysmS involving the iliac bifurcation (pELVIS) Registry included 575 patients undergoing 650 IBD implantations with ZBIS (Cook Medical) or Gore (WL Gore & Associates ) IBDs. This retrospective analysis of prospectively collected data by prearranged protocols of the first six European vascular centres (Münster, Florence, Rome, Thessaloniki and Perugia) was published in 2017 and it showed good mid-term patency (at 32.6±9.9 months clinical follow-up) with a low reintervention rate (7.3%). In this same year, universities in Lille, Hamburg and Leipzig joined the registry. The aim of this report is to provide the latest longterm evidence and to evaluate the performance of IBDs in challenging conditions outside their normal usage.